DES MOINES ONCOLOGY RESEARCH ASSOCIATION (EIN 475634159) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2015

Legal Domicile

Principal Officer

DR ROBERT BEHRENS

Phone

5152413305

Tax Period

2024-01-01 to 2024-12-31

DES MOINES ONCOLOGY RESEARCH ASSOCIATION, founded in 2015, is a micro nonprofit in the Medical Research sector that reported $100K in total revenue in fiscal year 2024. Revenue fell 73% from the prior year — a significant decline worth monitoring. Expenses of $148K exceeded revenue, resulting in a 48% operating deficit.

Mission

DES MOINES ONCOLOGY RESEARCH ASSOCIATION (DORA) IS ORGANIZED EXCLUSIVELY FOR SUPPORTING CANCER RESEARCH IN THE DES MOINES, IOWA AREA. DORA WILL RESPONSIBLY OVERSEE THE CONDUCT OF CANCER RESEARCH TRIALS AND SUPERVISE APPROPRIATE MANAGEMENT OF FUNDS FROM INDUSTRY SPONSORS OF RESEARCH TRIALS OR FROM PHILANTHROPIC DONATIONS TO SUPPORT LOCAL CANCER RESEARCH.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $93,056

Investment Income $6,855

Other Revenue $0

TOTAL REVENUE $99,911

Expense Breakdown

Grants Paid $0

Salaries & Benefits $128,009

Fundraising Expenses $0

Program Expenses $133,386

Other Expenses $20,198

TOTAL EXPENSES $148,207

Year-over-Year Comparison

	2024	2023	Change
Revenue	$99,911	$363,331	-0.7%
Expenses	$148,207	$243,939	-0.4%
Net Income	$-48,296	$119,392	-1.4%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ROBERT BEHRENS MD	PRESIDENT	1.00	Officer Director	$0	$0	$0
JOSHUA LUKENBILL MD	VICE PRESIDENT	1.00	Officer Director	$0	$0	$0
TARA GRAFF MD	SECRETARY/TREASURER	1.00	Officer Director	$0	$0	$0
SHANNON BENSON	EXECUTIVE DIRECTOR	1.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$99,911	$148,207	$873,472	$-48,296
2023	$363,331	$243,939	$921,767	$119,392
2022	$166,813	$102,682	$802,375	$64,131
2021	$333,177	$84,225	$738,244	$248,952

DES MOINES ONCOLOGY RESEARCH ASSOCIATION